Is it best to obtain informed consent from schizophrenic patients about the possible risk of drug treatment, for example, tardive dyskinesia, before initiating treatment or at a later date?
- 1 June 1983
- journal article
- question the-experts
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 3 (3), 207-8
- https://doi.org/10.1097/00004714-198306000-00036